NCT02023489 |
|
Lipid and Glycogen Metabolism in Patients With Impaired Glucose Tolerance and Calcium Sensing Receptor Mutations
|
View
|
NCT01466335 |
|
An Adaptive Phase I Study to Evaluate the Safety Efficacy and Dose Responses of Ronacaleret in Healthy Human Volunteers
|
View
|
NCT03994172 |
|
Novel Combination Therapy for Osteoporosis in Men
|
View
|
NCT04872894 |
|
Familial Hypocalciuric Hypercalcemia Clinical Aspects and Evolution
|
View
|
NCT01228786 |
|
Regulation of Vitamin D Receptor VDRCalcium Sensing Receptor CaSR Cyclin D1Ki67 and Proliferating Cell Nuclear Antigen PCNA in Primary Hyperparathyroidism
|
View
|
NCT02824718 |
|
Recombinant Human rhPTH1-34 VS Association AlfacalcidolHydrochlorothiazide in Severe Primary Hypoparathyroidism
|
View
|
NCT03051308 |
|
University of Wisconsin Solution Versus New Parathyroid Transport Solution for Parathyroid Allotransplantation
|
View
|
NCT05227287 |
|
ADH1 and ADH2 Disease Monitoring Study DMS
|
View
|
NCT00926341 |
|
The Effects of Peroxisome Proliferators Activated Receptor-Gamma PPAR-γ Agonists on Certain Biochemical and Inflammatory Markers in Metabolic Syndrome
|
View
|
NCT01021280 |
|
Parathyroid Hormone PTH Homeostasis in Bartter Syndrome
|
View
|
NCT02894047 |
|
Study of the Influence of the Expression of the Calcium-sensitive Receptor CaSR by Monocytes in the Synovial Liquid on Structural Alterations in Patients Diagnosed With Rheumatoid Arthritis in the Previous Two Years
|
View
|
NCT03831620 |
|
The Crosstalk Between Calcium-sensing Receptor Signaling and Endocannabinoid System in Primary Hyperparathyroidism
|
View
|